View details of this raise on Seedstage

Chicago, IL

Scaling wearable vital signs monitoring to improve patient care in low-resource hospitals.

• Proven traction: 124% sales growth in the past year and 30+ hospitals onboarded.
• Regulatory readiness: CE-marked, patented, and ISO 13485 certified for clinical use.
• Impact-driven team: Led by Columbia-trained biomedical engineers with global healthcare experience.
• Product innovation pipeline: neoSpot and neoCloud expand use cases and add recurring revenue.
• Global recognition: Endorsed by UN Women, WHO, and UNITAID for healthcare innovation.

Neopenda is raising funds to scale its wearable health technology designed to support overburdened healthcare workers in low-resource settings. The company’s flagship product, neoGuard, is a clinically regulated, medical-grade wearable that tracks key vital signs—pulse, oxygen saturation, respiratory rate, and temperature—and delivers real-time monitoring and alerts for patient deterioration. Developed specifically for emerging markets, neoGuard is already deployed in over 30 hospitals in Kenya and has logged more than 35,000 hours of patient data. With validation from organizations such as the UN, WHO, and UNITAID, and backing from investors including Techstars and Vodafone, Neopenda is positioned to expand its reach throughout Sub-Saharan Africa.

This fundraising round will support Neopenda’s continued geographic expansion, enhancement of manufacturing and distribution capacity, and development of new products like neoSpot and neoCloud. These new offerings will broaden use to all age groups and introduce data analytics tools and subscription-based revenue streams. With a market opportunity in Sub-Saharan Africa exceeding $3.4 billion and growing healthcare demand, Neopenda’s technology provides scalable tools to help clinicians deliver more efficient and timely care. The company is led by a team of biomedical engineers with deep experience in clinical technology development and implementation in low-resource environments. Neopenda is creating a platform for data-driven care with a long-term vision to improve patient outcomes across the healthcare system.

Company Info

Neopenda develops wearable vital signs monitors for hospitals in low-resource settings to improve early detection and care delivery.

Neopenda is a healthtech company that develops and deploys vital signs monitoring solutions tailored to resource-constrained healthcare settings, with a focus on Sub-Saharan Africa. Its flagship product, neoGuard, is a wearable medical device that tracks pulse rate, oxygen saturation, respiratory rate, and temperature. Designed for low-resource hospitals, neoGuard provides nurses and doctors with real-time alerts and centralized patient data to prioritize care and respond proactively to patient deterioration. The system is purpose-built for environments where high patient-to-nurse ratios and unreliable infrastructure create barriers to effective monitoring.

Since launching in Kenya, Neopenda has expanded to over 30 hospitals, tracking more than 35,000 hours of patient data. The company is led by a team of biomedical engineers from Columbia University and supported by grants and investments from organizations such as Vodafone, Cisco, and Techstars. Neopenda owns its IP and operates under regulatory frameworks such as CE marking and ISO 13485. Looking ahead, it plans to broaden its market reach across Africa, scale its product offerings to include at-home and cloud-based solutions, and introduce a subscription model to expand revenue streams.